These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative properties of the three groups of splenic beta-glucosidase molecular forms. Salvayre R, Maret A, Negre A, Douste-Blazy L. Prog Clin Biol Res; 1982; 95():443-52. PubMed ID: 6812080 [No Abstract] [Full Text] [Related]
4. Multiple forms of beta-glucosidase in Gaucher disease. Yaqoob M, Carroll M. Prog Clin Biol Res; 1982; 95():453-63. PubMed ID: 6812081 [No Abstract] [Full Text] [Related]
5. The beta-glucosidase isozymes and the enzymatic defect in Gaucher disease. Patrick AD. Prog Clin Biol Res; 1982; 95():287-308. PubMed ID: 6812075 [No Abstract] [Full Text] [Related]
6. [Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)]. Maret A, Salvayre R, Negre A, Douste-Blazy L. Eur J Biochem; 1981 Apr; 115(3):455-61. PubMed ID: 6786882 [No Abstract] [Full Text] [Related]
7. Homozygote and heterozygote identification. Wenger DA, Roth S. Prog Clin Biol Res; 1982 Apr; 95():551-72. PubMed ID: 6812086 [No Abstract] [Full Text] [Related]
9. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen. Butterworth J, Broadhead DM. Clin Chim Acta; 1978 Aug 01; 87(3):433-40. PubMed ID: 28186 [Abstract] [Full Text] [Related]
10. Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease. Gatt S, Dinur T, Desnick RJ. Prog Clin Biol Res; 1982 Aug 01; 95():315-31. PubMed ID: 6812076 [No Abstract] [Full Text] [Related]
12. Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase. Carroll M. J Inherit Metab Dis; 1985 Aug 01; 8(1):33-7. PubMed ID: 3921758 [Abstract] [Full Text] [Related]
13. Soluble and membranous neutral beta-glucosidases. Ben-Yoseph Y, Nadler HL. Prog Clin Biol Res; 1982 Aug 01; 95():465-80. PubMed ID: 6812082 [Abstract] [Full Text] [Related]
14. Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher disease. Maret A, Potier M, Salvayre R, Douste-Blazy L. FEBS Lett; 1983 Aug 22; 160(1-2):93-7. PubMed ID: 6411492 [Abstract] [Full Text] [Related]
15. Assay of the beta-glucosidase activity with natural labelled and artificial substrates in leukocytes from homozygotes and heterozygotes with the Norrbottnian type (Type 3) of Gaucher disease. Svennerholm L, Håkansson G, Dreborg S. Clin Chim Acta; 1980 Sep 25; 106(2):183-93. PubMed ID: 6773705 [Abstract] [Full Text] [Related]
17. Genetic heterogeneity in type I Gaucher disease. Devine EA, Beighton P, Petersen EM, Desnick RJ. Prog Clin Biol Res; 1982 Sep 25; 95():495-510. PubMed ID: 6812084 [Abstract] [Full Text] [Related]
18. [Beta-glucosidases. Molecular bases of Gaucher's disease]. Maret A, Salvayre R, Negre A, Douste-Blazy L. Pathol Biol (Paris); 1985 Jun 25; 33(6):693-713. PubMed ID: 3931039 [Abstract] [Full Text] [Related]
19. Physical and kinetic properties of beta-glucosidase in Gaucher disease. Karazeh A, Carroll M. J Inherit Metab Dis; 1983 Jun 25; 6(3):101-4. PubMed ID: 6422137 [Abstract] [Full Text] [Related]
20. Beta-glucosidase activity in liver, spleen and brain in acute neuropathic Gaucher disease. Takahashi T, Nishio H, Kodama S, Nakamura H. Brain Dev; 1990 Jun 25; 12(2):202-5. PubMed ID: 2113779 [Abstract] [Full Text] [Related] Page: [Next] [New Search]